CLARIFICATION WILL AVOID UNNECESSARY ANIMAL TESTS

Unnecessary animal tests will be avoided and costs to industry reduced as a result of a new clarification of the information requirements for manufacturers and importers of chemical substances under the REACH regulation. The clarification is specific. It applies to companies manufacturing or importing substances at quantities greater than or equal to 100 tonnes (and 1000 tonnes) per year who need to provide information in their registration dossiers on the repeated dose toxicity or reproductive toxicity of their substance. Put simply, companies who need to provide information based on long term toxicity studies1, do not need to also submit the results of screening or short term studies2 in order for their submission to be considered “complete” by the European Chemicals Agency. Companies are encouraged to consult the Agency’s fact sheet for the complete clarification to enable them to decide which information they need to provide for their dossiers to pass the technical completeness check. The clarification is one further contribution for companies to consider as part of an integrated approach to obtaining the information necessary to determine the hazards and risks that their substances may present for human health and the environment. When a dossier has passed the completeness check, a registration number is provided to the company who can then continue to manufacture, import and market the substance. ECHA emphasises that the information requirements constitute the minimum information required for a technical dossier to pass the completeness check for the two particular hazard endpoints - repeated dose toxicity and reproductive toxicity - and that additional information may be necessary to comply with the REACH legislation and to ensure safe use. Registrants who decide to submit testing proposals for the longer term studies without having completed the shorter ones must take account of that by including in the Chemical Safety Report and in the exposure scenario the interim risk management measures that they put in place and those they recommend to downstream users in order to manage the risks yet to be explored. The responsibility for the safe use of the chemical lies with the manufacturers, importers and downstream users.